Biotech / MedTech
South Korea’s S&S Lab partners Singapore’s FVC to support biotech and foodtech startups
South Korea’s private sector-led shared research lab S&S Lab (the operator of IRIS Lab) has announced its latest strategic partnership with Singapore innovation ecosystem enabler Farquhar VC (FVC), to foster and deepen relations among Korean and global novel food and biotech startups.
Indonesian biotechnology startup Moosa Genetics raises new funding led by East Ventures
Moosa Genetics, an animal genomics and biotechnology startup based in Indonesia, has on Monday announced that the company raised funding led by East Ventures, a venture capital firm focusing on Southeast Asia. The funding also saw the participation from angel investors.
Automera secures $16M in Series A funding co-led by ALSP, ClavystBio
Automera, a new biotechnology company based in Singapore, has secured $16 million in Series A funding co-led by Accelerator Life Science Partners (ALSP) and ClavystBio. The funding also saw participation from Singapore-based global investor EDBI, Xora Innovation, and other undisclosed investors.
InnovaTalk Webinar recap: Understanding medication-gut microbiome interactions
The July InnovaTalk Webinar hosted by the VinFuture Foundation highlighted the most recent research endeavors in understanding the interaction between medication drugs and the human gut microbiome, their implications on various complications including Antimicrobial Resistance and malnutrition, and challenges and opportunities to expand microbiome research…
Hong Kong’s Immuno Cure completes $12M first close of Series A financing led by Gobi Partners
Hong Kong-based biotech firm Immuno Cure BioTech (Immuno Cure) announced Thursday that it has closed the $12 million tranche in the $27 million Series A fundraising round. Led by the AEF Greater Bay Area Fund that Gobi Partners GBA (Gobi GBA) manages, this round will be used to accelerate the development of DNA vaccines and antibodies, as well as to prepare…
500 Global-backed Thai food biotech firm IncreBio to launch products in Singapore by year-end
The company has raised over $2 million from 500 Global, TOP Ventures (CVC-arm of Thai Oil PLC) and angel investors—from a group of former executives of Coca-Cola, PepsiCo and Dole, to a family office of one of the largest healthcare networks in Southeast Asia.
Singapore’s Mirxes to list in Hong Kong after securing $50M in Series D funding
Mirxes Holding Company Limited, a Singapore-headquartered biotech firm, announced Tuesday that it has filed listing application with The Stock Exchange of Hong Kong Limited after securing $50 million Series D funding.
Singapore yellow biotech firm Ento Industries raises growth funding to ramp up production capabilities
Singapore home-grown biotechnology start up Ento Industries has secured growth funding from a pair of environmental, social and governance (ESG)-focused private investors Tak Wai CHUNG and Te-LingNAI. The funding will expedite the firm's move to a larger facility and ramp up its production capabilities.
Germany’s BLUU Seafood aims to launch cultivated seafood products in Singapore in 2024
BLUU Seafood, a Germany-based food biotech that produces cultivated fish, aims to launch the first cultivated seafood products in Singapore in 2024 after securing Series A funding. After securing EUR 16 million ($17.36 million), the firm has secured the necessary capital to further advance the work on its groundbreaking technology and to enable the market…
Singapore’s Apeiron Bioenergy raises $37M through investment grade green bond
Apeiron Bioenergy (Apeiron), a Singapore-based integrated global player in bioenergy, has raised SGD 50 million ($36.95 million) through the landmark issuance of a five-year senior unsecured green bond guaranteed by Credit Guarantee and Investment Facility (CGIF), a trust fund of the Asian Development Bank.
